Social and economic factors, including unemployment, being unmarried, or living in disadvantaged neighborhoods, are linked to poorer cognitive skills in adults with multiple sclerosis (MS), especially among non-white people, according to a U.S. study. The findings add to earlier evidence that patients with a lower socioeconomic status, tend…
Discussion
Early treatment with high-efficacy disease-modifying therapies (DMTs) lowered the risk of relapse-associated disability progression in people with multiple sclerosis (MS), but had no effect on disability progression independent of relapse activity (PIRA), a nationwide study in Denmark found. People who received high-efficacy therapies as a first treatment were…
Discussion
Both the Mediterranean diet and time-restricted eating — a dietary intervention in which all daily meals and snacks are consumed within a set time window — may help promote weight loss in people with relapsing-remitting multiple sclerosis (RRMS), according to results from a small clinical trial comparing the two…
Discussion
There is a beautiful, humbling irony in the rhythm of my life. When I was in my 20s, Bike MS — a cycling series to raise money for multiple sclerosis (MS) research and support that includes a two-day, 150-mile ride known as the MS 150 —…
Discussion
Ocrevus (ocrelizumab) and Kesimpta (ofatumumab) are both highly effective at preventing relapses and disability worsening in people with relapsing-remitting multiple sclerosis (RRMS) in real-world clinical practice, though data show small differences in their clinical profiles. While Ocrevus was linked to fewer relapses and Kesimpta to a lower…
Get regular updates to your inbox.
